The present invention relates to a pharmaceutical composition comprising an insulin compound in a concentration that is sufficient to maintain a therapeutically effective level of the insulin compound in blood plasma for at least 3 days characterized by having a pharmacokinetic profile in vivo with substantially no burst of the insulin compound. The present invention further relates to the use of an insulin compound for preparing said pharmaceutical composition as well as a kit of parts comprising said pharmaceutical composition.
申请公布号
SG178195(A1)
申请公布日期
2012.03.29
申请号
SG20120006847
申请日期
2010.07.30
申请人
SANOFI-AVENTIS DEUTSCHLAND GMBH
发明人
SPROGOEE, KENNETT;CLEEMANN, FELIX;HERSEL, ULRICH;KADEN-VAGT, SILVIA;LESMANN, TORBEN;RAU, HARALD;WEGGE, THOMAS